Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Atrophic Vaginitis (Phase 3)
Dyspareunia (Phase 1)
Endometrial Hyperplasia (Phase 4)
Epistaxis (Phase 2)
Menopause (Phase 2)
Multiple Sclerosis (Phase 2/Phase 3)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Pelvic Organ Prolapse (Phase 4)
Prolapse (Phase 4)
Sexual Dysfunction, Physiological (Phase 1)
Telangiectasia, Hereditary Hemorrhagic (Phase 2)
Urinary Bladder, Neurogenic (Phase 2/Phase 3)
Vaginal Diseases (Phase 4)
Vaginitis (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue